This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Sahota, A, Yang, M, McDaniel, HB, Sidner, RA, Book, B, Barr, R, Brahmi, Z & Jindal, RM Evaluation of seven PCR-based assays for the analysis of microchimerism. Clin Biochem, (1998). 31, 641–645.
Thiede, C, Florek, M, Bornhauser, M, Ritter, M, Mohr, B, Brendel, C, Ehninger, G & Neubauer, A Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection. Bone Marrow Transplant, (1999). 23, 1055–1060.
Pindolia, K, Janakiraman, N, Kasten-Sportes, C, Demanet, C, Van Waeyenberge, C, Pals, G & Worsham, MJ Enhanced assessment of allogeneic bone marrow transplant engraftment using automated fluorescent-based typing. Bone Marrow Transplant, (1999). 24, 1235–1241.
Lion, T & Muller-Berat, N Chimerism testing after allogeneic stem cell transplantation: importance of timing and optimal technique for chimerism testing in different clinical-biological situations. Leukemia, (1999). 13, 2059
Lion, T Chimerism testing after allogeneic stem cell transplantation: importance of timing and optimal technique for chimerism testing in different clinical–biological situations. Leukemia, (2001). 15, 292
Thiede, C, Bornhauser, M, Oelschlagel, U, Brendel, C, Leo, R, Daxberger, H, Mohr, B, Florek, M, Kroschinsky, F, Geissler, G, Naumann, R, Ritter, M, Prange-Krex, G, Lion, T, Neubauer, A & Ehninger, G Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem cell transplantation (BSCT) using multiplex PCR amplification of short tandem repeat-markers. Leukemia, (2001). 15, 293–302.
Bader, P, Klingebiel, T, Schaudt, A, Theurer-Mainka, U, Handgretinger, R, Lang, P, Niethammer, D & Beck, JF Prevention of relapse in pediatric patients with acute leukemias and MDS after allogeneic SCT by early immunotherapy initiated on the basis of increasing mixed chimerism: a single center experience of 12 children. Leukemia, (1999). 13, 2079–2086.
Gilliland, G, Perrin, S, Blanchard, K & Bunn, HF Analysis of cytokine mRNA and DNA: detection and quantitation by competitive PCR chain reaction. Proc Natl Acad Sci USA, (1990). 87, 2725–2729.
Dubovsky, J, Daxberger, H, Fritsch, G, Printz, D, Peters, C, Matthes, S, Gadner, H & Lion, T Kinetics of chimerism during the early post-transplant period in pediatric patients with malignant and non-malignant hematologic disorders: implications for timely detection of engraftment, graft failure and rejection. Leukemia, (1999). 13, 2060–2069.
Bader, P, Stoll, K, Huber, S, Geiselhart, A, Handgretinger, R, Niemeyer, C, Einsele, H, Schlegel, PG, Niethammer, D, Beck, J & Klingelbiel, T Characterization of lineage-specific chimaerism in patients with acute leukaemia and myelodysplastic syndrome after allogenic stem cell transplantation before and after relapse. Br J Haematol, (2000). 108, 761–768.
Lion, T, Daxberger, H, Dubovsky, J, Filipcik, P, Fritsch, G, Printz, D, Peters, C, Matthes-Martin, S, Lawitschka, A & Gadner, H Analysis of chimerism within specific leucocyte subsets for detection of residual or recurrent leukemia in pediatric patients after allogenic stem cell transplantation. Leukemia, (2001). 15, 307–310.
Lion, T & Muller-Bérat, N Chimerism testing after allogeneic stem cell transplantation: importance of timing and optimal technique for testing in different clinical–biological situations. Leukemia, (2001). 15, 1966
Shimoni, A & Nagler, A Non-myeloablative stem cell transplantation (NST): chimerism testing as guidance for immune-therapeutic manipulations. Leukemia, (2001). 15, 1967–1975.
Klingebiel, T, Niethammer, D, Dietz, K & Bader, P Progress in chimerism analysis in childhood malignancies: the dilemma of biostatistical considerations and ethical implications. Leukemia, (2001). 15, 1989–1991.
Lawler, M Prospective chimerism analysis, the time is now but can we respond?. Leukemia, (2001). 15, 1992–1994.
Biondi, A & Balduzzi, A Commentary. Leukemia, (2001). 15, 1995
Mattsson, J, Uzunel, M, Tammik, L, Aschan, J & Ringden, O Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell transplantation. Leukemia, (2001). 15, 1976–1985.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Acquaviva, C., Duval, M., Mirebeau, D. et al. Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Paris–Robert Debré experience. Leukemia 17, 241–246 (2003). https://doi.org/10.1038/sj.leu.2402762
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402762
Keywords
This article is cited by
-
The EuroChimerism concept for a standardized approach to chimerism analysis after allogeneic stem cell transplantation
Leukemia (2012)
-
Engraftment of unrelated cord blood after reduced-intensity conditioning regimen in children with refractory neuroblastoma: a feasibility trial
Bone Marrow Transplantation (2011)
-
Quantitative monitoring of multi-donor chimerism: a systematic, validated framework for routine analysis
Bone Marrow Transplantation (2010)
-
Assessing quantitative chimerism longitudinally: technical considerations, clinical applications and routine feasibility
Bone Marrow Transplantation (2007)
-
Chimerism analysis within 6 months of allogeneic stem cell transplantation predicts relapse in acute myeloid leukemia
Bone Marrow Transplantation (2007)